A new weight-loss drug that produced jaw-dropping clinical trial results in early 2021 may be the ammunition needed to get you to your weight-loss goal. Semaglutide, a once a week subcutaneous injection (diabetic needle) is already approved by the Food and Drug Administration as a treatment for Type 2 diabetes, produced moderate weight loss at its dose of 1 milligram weekly. Participants lost an average of 37 pounds through Semaglutide and diet changes.

Semaglutide is a safe, doctor-prescribed GLP-1 medication prescribed under the brand names Wegovy®, Ozempic®, and Rybelsus®.

Semaglutide is part of a class of medications called GLP-1 receptor agonists, or glucagon-like peptide-1 receptor agonists. It increases insulin secretion, which is good for diabetes. But at higher doses, it acts on centers in the brain and suppresses appetite. At the same time it slows down gastric emptying. In return you stay full longer and eat less.

What this medicine does is help patients adhere to a reduced-calorie diet. It is important to use this medication in conjunction with lifestyle intervention. With obesity, you always need lifestyle changes plus medicine.

Semaglutide should be used with a reduced-calorie meal plan and increased physical activities for best results. Semaglutide should not be used with other Semaglutide-containing products or GLP-1 receptor agonist medicines. “You always have to consider nausea, vomiting, diarrhea, constipation” as potential side effects, he said. “But these are very manageable. Those tend to come on early in treatment and get better over time.

We know it’s hard to lose weight, but we can help. Our team of medical experts will work with you and your body chemistry so that the pounds come off fast!

We know that the best diets incorporate sustainable, scientific approaches to weight loss. That’s why our treatments work inwards on your body and outwards through improved mental well-being!